Tokaido Health provides AI-native medication steerage anchored in behavioral economics to counter incentive distortions in medication sourcing and administration. Its platform offers site-of-care steerage, biosimilar substitution, formulary optimization, and polypharmacy reconciliation, paired with loss-framed incentives to encourage members to switch to lower-cost options. The company layers its concierge services on top of existing benefits ecosystems and manages the operational work to make switching effortless for members. The announcement named the founding team and advisors and stated the company is hiring technical, clinical, operations, and sales staff. Tokaido disclosed $25 million committed from a group of investors to support building and scaling its product and team.

Total raised

$25M

Funding rounds

1

Latest round

Equity

Latest activity

May 2026